Development of biosimilars in an era of oncologic drug shortages

biosimilars

..... Preclinical and clinical characterization is ongoing for potential biosimilars of trastuzumab, rituximab, and bevacizumab, with promising results.

Keywords: biologics, monoclonal antibody, cancer, rituximab, safety, trastuzumab

Download Article [PDF]